PC(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))

Metabolite details

Identifier

LJFKFKIYUJNFPZ-ZLFSCUDPSA-N

InChI Key

LJFKFKIYUJNFPZ-ZLFSCUDPSA-N

IUPAC name

[(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyl]oxy-3-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(20:1(11Z)/20:4(5Z,8Z,11Z,14Z))

INN name

—

Synonym

—

ChEBI

CHEBI:184140

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• Mechanical force promotes dimethylarginine dimethylaminohydrolase 1-mediated hydrolysis of the metabolite asymmetric dimethylarginine to enhance bone formation
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_AONFH_Stage_III_IV
• Control_vs_Exercise
• Control_Female_vs_Restricted_Female
• Knockdown_vs_Control
• Knockdown_vs_Control